Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
McKesson
Novartis
Johnson and Johnson
Cantor Fitzgerald
Moodys
Daiichi Sankyo
AstraZeneca
Fish and Richardson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,462,983

« Back to Dashboard

Summary for Patent: 4,462,983
Title: Certain ergot peptide alkaloids administered to the nasal mucosa
Abstract:The present invention provides a nasal or pulmonary pharmaceutical composition comprising as active agent a compound of formula I, ##STR1## wherein R.sub.1 is hydrogen or halogen, R.sub.2 is hydrogen or alkyl of 1 to 4 carbon atoms, either (i) R.sub.3 is isopropyl, sec-butyl, or isobutyl, R.sub.4 methyl, ethyl or isopropyl and R.sub.5 is hydrogen and R.sub.6 is hydrogen or methoxy or R.sub.5 and R.sub.6 are together a single bond, or (ii) R.sub.3 is benzyl, R.sub.4 is methyl, R.sub.5 is hydrogen and R.sub.6 is hydrogen or methoxy, or (III) dihydroergocristine, in association with a pharmaceutically acceptable carrier or diluent, adapted for nasal or pulmonary administration.
Inventor(s): Azria; Moise (Paris, FR), Cavanak; Thomas (Oberwil, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/328,680
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 4,462,983

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,462,983

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland14575/76Nov 19, 1976
Switzerland6989/77Jun 07, 1977

International Patents Family Members for US Patent 4,462,983

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 368881 ➤ Subscribe
Austria A825477 ➤ Subscribe
Australia 3078377 ➤ Subscribe
Australia 520754 ➤ Subscribe
Belgium 860938 ➤ Subscribe
Canada 1103585 ➤ Subscribe
Czechoslovakia 228502 ➤ Subscribe
Czechoslovakia 228523 ➤ Subscribe
Cyprus 1266 ➤ Subscribe
Germany 2750090 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Medtronic
Healthtrust
Colorcon
US Department of Justice
Teva
Johnson and Johnson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot